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WHAT THIS PAPER ADDS
 This paper reviews radiation doses for patients undergoing EVAR procedures in a dedicated hybrid operating theatre. The potential
for inducing both stochastic and deterministic effects, and the separate methods of estimating whole body and skin dose, are
examined. A review of the literature reveals awide range of conversion factors are used in estimating whole body effective dose and
the difﬁculties in arriving at accurate dose estimates are discussed. We review the latest guidelines for patient follow up where the
potential for skin injury is suspected. Finally we develop a novel training tool to support dose optimisation.a r t i c l e i n f o
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The study assessed radiation exposure during EVAR. Two types of patient dose were estimated: effective
dose (ED), which allows estimation of radiation risk to the EVAR patient population; and Peak Skin Dose
(PSD), which allows us assess the potential for an individual patient to receive a radiation skin injury. An
ancillary aim was to examine dose optimization in EVAR procedures.
Based on 111 EVAR cases we estimated average ED as 12.4 mSv. Cumulative patient dose in our centre
was lower than other studies because the follow up of EVAR patients is based on ultrasound rather than
CT. PSD calculated using a published conversion formula closely matched measurements with calibrated
gafchromic ﬁlm. 99% of patients had an estimated PSD of < 2Gy. Results indicate that skin injuries are
possible, but very unlikely in EVAR procedures at our centre.
EVAR is a high dose procedure and emphasis on dose optimisation is important. We broke the EVAR
procedure into 15 steps and, in a phantom study, showed how skin dose changes as procedure steps are
varied. The resulting dose matrix has the potential to be used as an educational tool to promote dose
optimization.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
In Endovascular Aneurysm Repair (EVAR) procedures, ﬂuoros-
copy is used to guide the positioning of endovascular grafts during
repair of abdominal aortic aneurysms. The use of ﬂuoroscopy avoids
the need for surgical repair under anaesthetic, but (EVAR) requires
the patient’s extended exposure to X-rays, before, during, and after
the intervention.1 Although interventional procedures are high dose
procedures, they typically cause less morbidity and mortality than
the equivalent surgical procedure.2 For high dose procedures anþ3531 4284137.
ciety for Vascular Surgery. Publishadditional emphasis on training for operators and on dose optimi-
zation is important.3e7 Justiﬁcation and optimization of radiation
doses and image quality, as well as the provision of appropriate
training and clinical audit are legislative requirements.6,7
The potential harmful effects of ionizing radiation are divided
into stochastic and deterministic effects. At low doses the main
potential for harm is the risk of stochastic effects, or cancer induc-
tion. Stochastic effectsmayoccur years or decades after an exposure.
Any dose is assumed to have the potential to cause harm with
increased dose increasing the probability that harm is caused.
Deterministic effects (tissue reactions) only occur with relatively
high radiation exposures and are usually evident within hours or
days of a radiation exposurewhich exceeds a threshold sufﬁcient toed by Elsevier Ltd. All rights reserved.
Table 1
Summary of radiation dose and ﬂuoroscopy times reported for EVAR procedures. n is
the number of patients in the study.
Study Mean DAP
Gycm2
Mean
Fluoroscopy
Time (mins)
Mean
Effective
Dose (mSv)
n
Kalef - Ezra et al. (2009) 42.5 22.6 6.2 62
Ho et al. (2007) e 13.0 12.7 30
Weerakkody et al. (2008) 150 21 27 96
Jones et al., 2010 46.8 29.4 11.7 320
Current study 85.8 18.5 12.4 111
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are very rare, but can occur in some interventional procedures.5,8e10
Injury thresholds for tissue and organs are well established in the
literature. Early transient erythema can occur 24e48 h post expo-
sures exceeding 2Gy, producing an injury resembling sunburn in an
area matching the shape of the X-ray ﬁeld. At higher doses skin
effects may be more severe and prolonged.8,9,11e13
The radiation dose parameter associated with the risk of
stochastic effects is effective dose (ED). Peak skin dose (PSD)
provides a good indicator of the potential for deterministic injury.
Neither ED nor PSD are routinely measured during procedures. The
main dose-related parameters available to the clinician during
interventional procedures are doseearea product (DAP), and
‘cumulative air kerma’ (CAK), which is sometimes termed ‘cumu-
lative dose’. DAP has been used to estimate both effective dose and
peak skin dose in previous studies, although the conversion factors
normally entail a degree of uncertainty or error.9e11 For example,
estimating PSD from DAP is problematic because during interven-
tional procedures the X-ray tube is moved around the patient, thus
irradiating different areas of skin.14
With the increase in endovascular radiology procedures,
vascular surgeons are now frequently involved in procedures using
ionizing radiation, which exposes both the operating team and the
patient to potential hazards. Interventionists are often unaware of
the amount of radiation applied to the skin during these proce-
dures.14 As one of the parameters affecting radiation dose is the
level of skill and experience,8 training is a key component of dose
optimization strategies.
In this study we assess radiation doses to patients undergoing
EVAR procedures in a dedicated, hybrid endovascular operating
theatre. Our primary aims were (i) to estimate effective dose (and
cancer risk) associated with EVAR procedures and (ii) to estimate
peak skin dose and so assess the potential for causing radiation
induced skin injuries during EVAR procedures.
As achieving these goals required a detailed study of the use of
ionizing radiation in EVAR procedures, an ancillary aim was to
explore opportunities for improving training and dose optimization
in EVAR procedures.
Material and Methods
EVAR procedures were conducted on a Siemens Multistar
Digital Fluoroscopy ﬁxed C-arm system. CTs pre and post EVAR
procedure were performed on a Siemens Somatom 64.
In order to estimate effective dose (ED), DAP and ﬂuoroscopy
times were collected retrospectively for 111 patients. ED was
calculated based on DAP values using published Dose Conversion
Coefﬁcients (DCCs). Our ED calculations were compared to EDs
recorded in EVAR procedures in four recent studies.1,15e17 The
inherent uncertainty implicit in the use of dose conversion coefﬁ-
cients is discussed. Radiation dose from CT exams associated with
the EVAR procedure is also considered. ED for CT is calculated from
DLP using a conversion factor of 0.017 mSv/mGycm.18
PSD was calculated from a published dose conversion formula
for interventional procedures as follows2:
PSD

mGy

¼ 249 þ 5:2 DAP Gy cm2 (1)
In addition to estimating PSD from the DAP, direct measurement
of entrance surface dose during EVAR procedures was performed
using calibrated gafchromic ﬁlm (XR-RV3, International Specialty
Products) for 8 EVAR procedures. The gafchromic ﬁlm was placed
between the table and the patient. The ﬁlm’s sensitivity range is
0.01 Gye30 Gy and it is speciﬁcally designed for skin dose
measurement. The ﬁlm was calibrated prior to use.The dose estimates above report the total radiation dose at the
end of the procedure, but don’t provide any information on how
that dose accumulates over the course of the procedure. Providing
a more detailed breakdown of radiation dose has the potential to
improve dose optimization. To show how radiation dose accumu-
lates over the course of the EVAR procedure, we broke the proce-
dure down into 15 steps and, in a phantom study, measured dose
rate or dose per frame for each step over a range of magniﬁcation
settings. This provided a measure of how entrance dose rate (which
may be used to approximate skin dose) varies with time and
magniﬁcation setting for each procedure step. 20 cm of water
equivalent material [PMMA] was used for the patient phantom.
Dose was measured using a calibrated probe [Radcal, 10X5-6]
placed against the surface of the PMMA at the X-ray tube side. This
method is based on a standard protocol for measuring entrance
surface dose.19 The data was entered into a standard spreadsheet
and linked to an interactive page or ‘dose matrix’. This has the
potential to be used as a training aid, focusing clinicians on how
radiation dose varies at each procedure step.Results
Mean DAP, ﬂuoroscopy time and ED for our retrospective audit
of 111 EVAR cases, and from four similar studies reported in the
literature,1,15e17 are summarized in Table 1. The additional radiation
doses due to CT exams are shown in Table 2.
Mean PSD, calculated fromDAP using Eq. (1) for our group of 111
patients, is 0.69 Gy. Maximum PSD was 3.15 Gy; the next highest
exposure for this group was 1.8 Gy. 99% of cases resulted in esti-
mated PSD of <2 Gy.
The dose distribution for a typical EVAR procedure, taken using
the gafchromic ﬁlm, is shown in Fig. 1. Average PSD for 8 patients
measured using gafchromic ﬁlm was 1.01 Gy; max PSD for this
group was 1.99 Gy. The PSD measured using gafchromic ﬁlm, and
the calculated PSD using Eq. (1), for the same group of patients is
shown in Table 3.
The dose rate per minute during ﬂuoroscopy, and the dose per
frame of digital exposure, for each procedure step in the phantom
study are recorded in Table 4. These values were used in the dose
matrix (Table 5).Discussion
The study assessed radiation exposure during EVAR. Two types
of patient dose were estimated: effective dose (ED), which allows
estimation of radiation risk to the EVAR patient population; and
Peak Skin Dose (PSD), which allows us assess the potential for an
individual patient to receive a radiation skin injury.
We estimated effective dose from the Dose Area Product (DAP)
using a dose conversion factor (DCC). Typically, conversion factors
are derived from measurements with anthropomorphic phantoms,
or taken from published data. Reviewing previous authors we note
Table 2
Effective dose from EVAR and associated CT scans.
Study CT Dose
(mSv)
No of
CTs
EVAR
dose
(mSv)
Total
Effective
Dose (mSv)
CT protocol
Kalef- Ezra 2009 11 5 6.2 61.2 (2 pre& 3 post)
Weerakkody
et al., 2008
13 4 27 79 (1 pre & 3 post)
Jones et al., 2010 8 4 11.7 43.7 1 pre and 3 post
Current Study 7.5 2 12.6 27.6 1 pre and 1 post CT
Table 3
Comparison between measured and calculated PSD.
Case PSD (Gy),
measured
PSD (Gy), calculated
from DAP
Difference in
calculated and
measured value (%)
1 0.98 0.94 4.46
2 0.75 1.09 þ31.78
3 1.99 1.92 3.86
4 1.12 0.89 25.74
5 0.99 1.12 þ14.99
6 0.86 0.79 7.86
7 0.73 0.78 þ6.29
8 0.65 0.79 þ18.4
Average 1.01 1.05 þ3.72
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vary from approximately 0.14 mSv/Gycm2 to 0.18 mSv/Gycm2 .In
one study a factor of 0.25 mSv/Gycm2 is used. We used a factor of
0.145 mSv/Gycm2 which accords with published data for the tube
geometry and the beam quality used in our procedures.1,20
Given the wide range in DCC used in each study, we use DAP
rather than ED for comparing exposure values. From Table 1, our
average exposure per procedure is towards the higher end of the
published values. A higher DAP implies longer procedure times and
more use of digital imaging. This in turn may be a consequence of
our use of a dedicated interventional room which provides the
capability to perform longer and more complex procedures than is
possible with a mobile c-arm. Training has also been identiﬁed as
a key factor affecting dose, and the dose matrix (discussed below)
has the potential to contribute to dose optimization by focusing
clinicians on operator variables which affect radiation dose at each
procedure step.
The comparison between ED is relevant if an optimum DCC has
been selected for each study. The correct choice of DCC depends on
a number of variables including patient characteristics, procedure
type, and machine and beam characteristics. Kemerink et al21 in
studying the effect of equipment set up on patient radiation dose in
angiography of the renal arteries calculated DCC ranging from 0.153
to 0.286 by varying equipment parameters. Dose studies employing
anthropomorphic phantoms may improve dose conversion accu-
racy, but the factors derived tend to be accurate for the speciﬁc
cases studied only. Problems with variations with DCC are not
unique to EVAR studies: Schultz and Zoeteleif22 have reported DCC
of 0.18e0.27 in PTCA procedures, again a considerable range for
ostensibly the same procedure type.
In general, ED estimates are subject to a number of simplifying
assumptions and as a consequence need to be treated with caution.
The ICRP3 recommends that ED is not used for risk calculations forFigure 1. Sample exposure pattern recorded on gafchromic ﬁlm during and EVAR
procedure. The ﬁlm is adjacent to the patient and depicts the distribution of skin dose.
Darker area indicate higher skin dose.individual patients. ED can be useful in risk estimates for pop-
ulations where the potential uncertainties (many of which are
strongly patient dependent) will average out over the population.
Depending on local protocols several CT scans directly associ-
ated with the EVAR procedure are performed. The CT scans repor-
ted in Table 2 are for the ﬁrst year only; many patients will continue
to receive CT scans as part of long term follow up. In some cases
a repeat endovascular procedure may be necessary, again adding to
the total dose. Considering the dose from one EVAR and the asso-
ciated CT scans in the year that the EVAR procedure was conducted
we see that CT scans contribute more to the total dose than the
EVAR study: in one centre a total CT dose of 55 mSv is delivered
over 5 exams. The main variables affecting CT dose are patient size,
and whether monophasic or multiphasic scans are performed. For
example, triphasic CT scans may be performed post an EVAR
procedure if a leak is suspected, signiﬁcantly increasing the radia-
tion dose for that scan. In our study there is limited use of CT:
routine CT scans were monophasic, with 5 mm slice thickness, and
ultrasound was used for follow up scans. The use of Ultrasound for
patient follow up was validated in a local study; similar studies
have been published in the literature.23
Assuming a risk of 5.5% per Sievert (fatal cancer all types)3 the
risk associated with the doses in Table 2 ranges from approximately
1 in 250 [0.39%] for the highest average dose to approximately 1 in
700 [0.14%] in our study. Risk from the EVAR procedure alone (i.e.
excluding the CTexams) is approximately 1 in 1500 [0.063%] for our
study. The largest contributing factor to ED is the total dose from
repeat CT studies. Consequently it is suggested that a primary
mechanism for dose control is review of justiﬁcation of CT scans,
with particular attention given to the potential for using alternate
lower dose diagnostic scans if adequate diagnostic information can
be obtained.
Radiation risk reduces with age due the long latency associated
with cancer induction. Survival rates for EVAR patients are lower
than a standard adult group and as such the radiation risk is
commensurately lower. Nonetheless the potential for cancer
induction is inevitably a factor for some patients, and the principle
of optimizing dose remains an imperative. While a lower risk mayTable 4
Entrance doses recorded in phantom study. FOV (Field of View) refers to the
magniﬁcation setting: FOV of 40 cm corresponds to Full ﬁeld, FOV of 36 cm corre-
sponds to Mag 1 and so on. Frequency of use refers to portion of the procedure
conducted at each FOV.
FOV (cm) Frequency
of use
Entrance surface dose,
Floursocopy 15 pps, mGy/min
Dose per frame,
digital mode, mGy
14 24% 15.60 3.83
20 44% 8.46 3.15
28 28% 5.32 1.94
36 4% 3.65 1.10
40 0% e e
Table 5
Dose Matrix. EVAR is broken into a series of procedure steps. The trainee enters values in the green cells. ﬂ ¼ ﬂuoroscopy; d ¼ digital acquisition. Skin dose per unit time in
ﬂuoroscopy/screening mode, or per digital frame in digital acquisition mode, are shown in column 4. Once a trainee has entered their selections, the skin dose estimate is
calculated automatically in column 7.
Step FOV fl/d Skin dose  (mGy) 
per minute (fl), 
or per frame (d).
Number of 
frames digital
Mins 
fluoroscopy
Skin Dose per 
Step (mGy)
Introduction of wires and 
catheters
28 fl 5.32 2 10.64
Introduction of main body
device
28 fl 5.32 1 5.32
Identification of renal 
arteries
14 d 3.83 30 114.9
Opening main body 20 fl 8.46 4 33.84
Confirmation of position 20 d 3.15 30 94.5
Introduction of wires and 
catheters
28 fl 5.32 1 5.32
Introduction of contralateral 
limb
20 fl 8.46 2 16.92
Confirm iliac position 28 d 1.94 12 23.28
Opening iliac limb 28 fl 5.32 2 10.64
Introduction of ipsilateral 
limb
28 fl 5.32 1 5.32
Confirm iliac position 20 d 3.15 9 28.35
Opening iliac limb 28 fl 5.32 2 10.64
Ballooning 20 fl 8.46 2 16.92
Confirmation run 28 d 1.94 100 194
Removal of wires 28 fl 5.32 1 5.32
Totals 181 18 575.91
Figure 2. Comparison between measured and calculated PSD.
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requirement to optimize the dose is in no way reduced.
Peak skin dose is not measured routinely, and as is the case with
ED estimates, numerous studies have suggested methods of esti-
mating PSD from DAP. The conversion formula we use (Eq. (1)) is
based on recent work published by the Society of Interventional
Radiology.2 Applying this formula we ﬁnd that there is a very low
potential for causing deterministic injury in our EVAR procedures
with average PSD estimated at 0.69 Gy, and 99% of procedures
having a PSD of <2 Gy. Our maximum estimated PSD (recorded
during a fenestrated procedure) was 3.15 Gy; no skin injury was
discovered on follow up of this patient.
Estimating PSD from DAP is potentially problematic because
during interventional procedures the X-ray tube is moved around
the patient thus irradiating different areas of skin. Typically an
C. Walsh et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 534e539538EVAR procedure involves both lateral and rotational movements,
and skin dose is spread from the top of the renals to the hip. We
took direct measurements with Gafchromic ﬁlm to assess the
accuracy of using the dose conversion formula for our procedures.
From Table 3, the average values for the measured and calcu-
lated PSD are within 5%. The correlation coefﬁcient is 0.83 (Fig. 2).
However, the difference between measured and calculated values
range from 26% to þ32% (Table 3). Thus, although we found good
correlation for our group of patients, skin dose was underestimated
by approximately 25% in one case.
The reason for estimating PSD is to establish whether a deter-
ministic injury may occur. Deterministic injuries, if they occur, may
not become evident until days or weeks after the procedure. At this
point a patient may no longer be in the hospital or in contact with
the team who carried out the radiation procedure and there is
a danger that the patient or their GP will not recognize the skin
injury as a radiation injury. Measurement of patient dose with
gafchromic ﬁlm is time consuming and impractical and the very
low potential for skin injury does not justify its use routinely.
Although the close agreement between our measurements with
gafchromic ﬁlm and the calculation from DAP support the use of
the calculation as a routine method of monitoring dose, the
potential to underestimate the dose is of concern.
Follow up levels based on machine exposure values have been
suggested in the literature to ensure that any potential skin injury is
identiﬁed. Suggested follow up thresholds are 500 Gycm2 (DAP) or
3 Gy (PSD).2,11e13 These levels are intended as a broad ﬁt for
interventional procedures and it is of value to verify their relevance
locally for procedures where there is the potential for causing
deterministic injuries. Our study suggests that the trigger level
could be lowered for EVAR procedures to allow for potential
underestimation of the PSD. In our case a reduction of approxi-
mately 50 Gycm2 should sufﬁce. It should also be noted that
500 Gycm2 threshold level is based on 3 Gy PSD follow up point.
2 Gy has also been suggested as a threshold dose for action, or 1 Gy
if the procedure was likely to be repeated; if a centre wishes to
follow up exposures that may lead to a 2Gy or 1Gy PSD, then the
threshold level needs to be reduced accordingly.2,5
We have chosen DAP as the main machine exposure parameter
of interest. Most modern machines also report cumulative dose,
which is accumulated at a speciﬁc point relative to the gantry, also
known as the interventional reference point. As with DAP, this
parameter does not take account of themovement of the X-ray ﬁeld
in relation to the patient. Fluoroscopy time is becoming less rele-
vant for dose estimates as digital acquisition accounts for an
increasing proportion of dose in interventional procedures. In our
study, digital exposure was found to outweigh ﬂuoroscopy expo-
sure by a factor of 1.22.
While we focus on EVAR procedures in this paper it is worth
noting that vascular interventional surgery is a developing area and
other, higher dose techniques are now also in use. For example
Punucci et al report doses of 103.1 mSv and 127.6 mSv for TAAA
type 4 and TAAA type 2 and 3 respectively. Mean PSDwas 5.4 Gy for
the most experienced operator and 7.7 Gy for others.24 As such it is
increasingly important that methods of dose monitoring are
implemented, and that training tools for high dose procedures are
continually developed and updated.
The dosematrix (Table 5), which combines clinical and phantom
data to show how patient dose can vary at each procedure step has
the potential to be used as a training aid.25 The EVAR procedure is
broken into 15 steps. The trainee selects ﬂuoroscopy or digital
acquisition, what magniﬁcation is used, and their time estimate for
each procedure step. A standard spreadsheet is programmed to link
their choices to the appropriate data from the phantom measure-
ments, and then perform simple calculations to provide a skin doseestimate. The trainee can continue to enter different values and
observe the change in calculated skin dose.
The sample data entered in the Table are based on a clinician’s
estimates of these values for a typical EVAR case. The ﬂuoroscopy
times and/or frame count (see Table 5, text in italics) have been
considerably underestimated; both are much lower than average
values recorded in our survey. Highlighting this discrepancy can
provide a useful means of focusing on each procedure step and the
attendant radiation exposure as part of a training exercise.
The dose matrix is not intended as a precise dose calculator, but
as a means of highlighting the effect of altering, extending or
reducing a procedure step on patient radiation dose. Gafchromic
ﬁlm also has the potential for use in training scenarios. Maintaining
the X-ray beam in the same place on the body for prolonged ﬂuo-
roscopy times will increase the dose. Varying the location of the
beam can help protect the skin.14 By depicting the spread in skin
dose during a typical procedure, gafchromic ﬁlm provides a visual
aid to demonstrating the effect of moving the X-ray tube relative to
the patient. Combined with instruction on geometric consider-
ations and collimation this provides an enhanced training tool,
focusing clinicians on how each procedure step contributes to
radiation dose to the patient.
Conclusion
Based on a review of DAP in 111 cases the average ED for EVAR
procedures at our centre is 12.4 mSv. Although EVAR is a high dose
procedure the patient can receive higher doses from the CT studies
performed pre and post the EVAR procedure. A primarymechanism
for dose control is to review the potential for using alternate, lower
dose diagnostic scans if adequate diagnostic information can be
obtained.
Average and maximum PSD were 0.69 Gy and 3.15 Gy respec-
tively; estimated PSD was <2Gy for 99% of the patients. Good
agreement was found between doses measured using gafchromic
ﬁlm and doses calculated from DAP. Skin injuries are highly
unlikely; a DAP value of 450 Gycm2 is suggested as an appropriate
threshold for patient follow up.
We broke down the EVAR procedure into 15 steps and con-
structed a matrix showing how skin dose varies as the procedure
steps are varied. The main application for the dose matrix is as
a training aid. As operator training has been identiﬁed in the
literature as a key factor in controlling radiation doses, improving
training tools has a strong potential for contributing to dose
optimization.
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